angioedema

(redirected from Hereditary angioedema)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Wikipedia.

angioedema

[‚an·jē·ō·i′dē·mə]
(medicine)
The development of giant hives beneath the surface of the skin, especially around the eyes and lips; usually due to an allergic response.
References in periodicals archive ?
Open-Label Use of Nanofiltered C1 Esterase Inhibitor (Human) (C1 INH-nf) for Treatment or Prophylaxis of Acute Attacks of Hereditary Angioedema (HAE) in Pregnant Subjects
As part of its commitment to improving the lives of patients with HAE in Europe, ViroPharma sponsors and funds the Hereditary Angioedema Burden of Illness Study in Europe (HAE-BOIS-Europe), an innovative, patient-centric, multi-country study of the humanistic and economic burden of HAE to address and improve current knowledge gaps surrounding the condition.
New insights into the pathophysiology of hereditary angioedema has led to the development of new treatment modalities that are promising in the treatment of acute attacks, although their role in short-term prophylaxis in the perioperative setting is yet to be defined.
Laryngeal edema and death from asphyxiation after tooth extraction in four patients with hereditary angioedema.
Dewald G, Bork K: Missense mutations in the coagulation factor XII gene in hereditary angioedema with normal C1 inhibitor.
Increased activity of coagulation factor Al (Hageman factor) causes hereditary angioedema type III.
Zingale of the University of Milan (Italy), and many coauthors, includes data from 1,168 patients in 527 families that are part of a European registry of hereditary angioedema.
Conclusions: Bradykinin may be important in the causality of the erythema marginatum associated with hereditary angioedema.
Food and Drug Administration yesterday approved Ruconest, the first recombinant C1-Esterase Inhibitor product for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema (HAE).
20, 2014 /PRNewswire/ -- CSL Behring today announced it has enrolled the first patient in COMPACT , an international phase III study of a volume-reduced, subcutaneous formulation of C1-esterase inhibitor (C1-INH) concentrate in patients with frequent hereditary angioedema (HAE) attacks (NCT01912456).
Adults and adolescents in Wales living with hereditary angioedema (HAE) - a rare and life threatening genetic disorder - now have access to ViroPharma's Cinryze [sup.
VIENNA -- The investigational bradykinin receptor antagonist icatibant appears to hold considerable therapeutic potential in episodes of hereditary angioedema, Konrad Bork, M.
Full browser ?